Comparative bioavailability of alpha-methyldopa normal and film tablet formulations after single oral administration in healthy volunteers

K. Róna, K. Ary, G. Renczes, B. Gachályi, Gy Grézal, S. Drabant, I. Klebovich

Research output: Contribution to journalArticle

2 Citations (Scopus)


In a single dose, randomized, cross-over study, with one week of wash-out period, the relative bioavailability of Dopegyt® tablets containing 250 mg alpha-methyldopa (AMD) and Presinol® film tablets with identical active ingredient content was examined in 24 healthy volunteers. Since technologically two completely different preparations (a film-tablet and a non-film-tablet) having significantly different in vitro dissolution were to be compared, both preparations were compared to a third one, AMD solution (Dopegyt® solution) with 250 mg/50 ml concentration. Plasma concentrations of the drug were measured for 24 hours post-dose, applying HPLC with fluorometric detection. Pharmacokinetic parameters calculated from individual data (AUCo-∞, AUCo-t, Cmax, Cmax/AUCo-∞ tmax) were evaluated statistically. Wilcoxon's nonparametric test and the four-way variance analysis could not detect any significant difference at the usual a=95% probability level in these pharmacokinetic parameters of the two tablet preparations. For AUCo-∞ at the 90% probability level, the confidence interval was 0.883-1.237 (with an estimated geometric mean of 1.045), for the test/reference ratio of Dopegyt® and Presinol® tablets, thus the two preparations proved to be bioequivalent. The relative bioavailability of Dopegyt® (test preparation) and Presinol® (reference preparation) calculated from the AUCo-∞ values was 116.7±56.7% that also confirmed bioequivalence. The results of all the applied statistical tests suggest that Dopegyt® and Presinol® can be considered as bioequivalent preparations.

Original languageEnglish
Article numberBF03190372
Pages (from-to)25-30
Number of pages6
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Issue number1-2
Publication statusPublished - Jan 1 2001



  • Alpha methyldopa
  • Bioavailability
  • Bioequivalence
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this